Literature DB >> 25171928

Predictors of dementia in Parkinson disease: a prospective cohort study.

Julius B M Anang1, Jean-Francois Gagnon2, Josie-Anne Bertrand1, Silvia Rios Romenets1, Veronique Latreille1, Michel Panisset1, Jacques Montplaisir1, Ronald B Postuma2.   

Abstract

OBJECTIVE: We investigated an array of possible markers of early dementia in Parkinson disease.
METHODS: We performed a comprehensive assessment of autonomic, sleep, psychiatric, visual, olfactory, and motor manifestations in 80 patients with Parkinson disease who were dementia-free at baseline. After 4.4 years' follow-up, patients were evaluated for dementia. Predictive variables were assessed using logistic regression adjusting for disease duration, follow-up duration, age, and sex.
RESULTS: Of 80 patients, 27 (34%) developed dementia. Patients destined to develop dementia were older and more often male (odds ratio [OR] = 3.64, p = 0.023). Those with baseline mild cognitive impairment had increased dementia risk (OR = 22.5, p < 0.001). REM sleep behavior disorder at baseline dramatically increased dementia risk (OR = 49.7, p = 0.001); however, neither daytime sleepiness nor insomnia predicted dementia. Higher baseline blood pressure increased dementia risk (OR = 1.37 per 10 mm Hg, p = 0.032). Orthostatic blood pressure drop was strongly associated with dementia risk (OR = 1.84 per 10 mm Hg, p < 0.001); having a systolic drop of >10 mm Hg increased dementia odds 7-fold (OR = 7.3, p = 0.002). Abnormal color vision increased dementia risk (OR = 3.3, p = 0.014), but olfactory dysfunction did not. Among baseline motor variables, proportion of gait involvement (OR = 1.12, p = 0.023), falls (OR = 3.02, p = 0.042), and freezing (OR = 2.63, p = 0.013), as well as the Purdue Pegboard Test (OR = 0.67, p = 0.049) and alternate tap test (OR = 0.97, p = 0.033) predicted dementia.
CONCLUSION: Cardiovascular autonomic dysfunction, REM sleep behavior disorder, color discrimination ability, and gait dysfunction strongly predict development of dementia in Parkinson disease.
© 2014 American Academy of Neurology.

Entities:  

Mesh:

Year:  2014        PMID: 25171928      PMCID: PMC4180482          DOI: 10.1212/WNL.0000000000000842

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  38 in total

1.  What predicts mortality in Parkinson disease?: a prospective population-based long-term study.

Authors:  E B Forsaa; J P Larsen; T Wentzel-Larsen; G Alves
Journal:  Neurology       Date:  2010-10-05       Impact factor: 9.910

2.  Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom.

Authors:  Peter Hobson; Jolyon Meara
Journal:  Mov Disord       Date:  2004-09       Impact factor: 10.338

3.  Color discrimination deficits in Parkinson's disease are related to cognitive impairment and white-matter alterations.

Authors:  Josie-Anne Bertrand; Christophe Bedetti; Ronald B Postuma; Oury Monchi; Daphné Génier Marchand; Thomas Jubault; Jean-François Gagnon
Journal:  Mov Disord       Date:  2012-11-12       Impact factor: 10.338

Review 4.  Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment.

Authors:  Per Svenningsson; Eric Westman; Clive Ballard; Dag Aarsland
Journal:  Lancet Neurol       Date:  2012-08       Impact factor: 44.182

Review 5.  A systematic review of prevalence studies of dementia in Parkinson's disease.

Authors:  Dag Aarsland; Julia Zaccai; Carol Brayne
Journal:  Mov Disord       Date:  2005-10       Impact factor: 10.338

6.  Orthostatic hypotension and attention in Parkinson's disease with and without dementia.

Authors:  C Peralta; M Stampfer-Kountchev; E Karner; M Köllensperger; F Geser; E Wolf; K Seppi; T Benke; W Poewe; G K Wenning
Journal:  J Neural Transm (Vienna)       Date:  2007-01-03       Impact factor: 3.575

7.  Rapid eye movement sleep behavior disorder and risk of dementia in Parkinson's disease: a prospective study.

Authors:  Ronald B Postuma; Josie-Anne Bertrand; Jacques Montplaisir; Catherine Desjardins; Mélanie Vendette; Silvia Rios Romenets; Michel Panisset; Jean-François Gagnon
Journal:  Mov Disord       Date:  2012-02-09       Impact factor: 10.338

8.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale.

Authors:  M W Johns
Journal:  Sleep       Date:  1991-12       Impact factor: 5.849

Review 9.  Visual dysfunction, neurodegenerative diseases, and aging.

Authors:  Gregory R Jackson; Cynthia Owsley
Journal:  Neurol Clin       Date:  2003-08       Impact factor: 3.806

Review 10.  Evolution of cognitive dysfunction in an incident Parkinson's disease cohort.

Authors:  C H Williams-Gray; T Foltynie; C E G Brayne; T W Robbins; R A Barker
Journal:  Brain       Date:  2007-05-29       Impact factor: 13.501

View more
  117 in total

1.  Is cognitive stability in Parkinson's disease a predictable phenomenon? A 5-year follow-up study.

Authors:  Maria Elena Di Battista; Alfonso Rubino; Marcella Valente; Patrizia Giustini; Nicola Vanacore; Giuseppe Meco
Journal:  J Neural Transm (Vienna)       Date:  2015-08-28       Impact factor: 3.575

2.  Electroencephalographic prodromal markers of dementia across conscious states in Parkinson's disease.

Authors:  Véronique Latreille; Julie Carrier; Benjamin Gaudet-Fex; Jessica Rodrigues-Brazète; Michel Panisset; Sylvain Chouinard; Ronald B Postuma; Jean-François Gagnon
Journal:  Brain       Date:  2016-02-16       Impact factor: 13.501

Review 3.  GBA-Associated Parkinson's Disease and Other Synucleinopathies.

Authors:  Ziv Gan-Or; Christopher Liong; Roy N Alcalay
Journal:  Curr Neurol Neurosci Rep       Date:  2018-06-08       Impact factor: 5.081

4.  [Successful aging: what can neurology and geriatrics contribute?].

Authors:  M Synofzik; W Maetzler
Journal:  Nervenarzt       Date:  2015-04       Impact factor: 1.214

5.  Akinetic rigid symptoms are associated with decline in a cortical motor network in Parkinson's disease.

Authors:  Sarah J Kann; Chiapei Chang; Peter Manza; Hoi-Chung Leung
Journal:  NPJ Parkinsons Dis       Date:  2020-08-24

6.  Cognitive Status, Gray Matter Atrophy, and Lower Orthostatic Blood Pressure in Older Adults.

Authors:  Celia O'Hare; Rose-Anne Kenny; Howard Aizenstein; Robert Boudreau; Anne Newman; Lenore Launer; Suzanne Satterfield; Kristine Yaffe; Caterina Rosano
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 7.  Cognitive decline in Parkinson disease.

Authors:  Dag Aarsland; Byron Creese; Marios Politis; K Ray Chaudhuri; Dominic H Ffytche; Daniel Weintraub; Clive Ballard
Journal:  Nat Rev Neurol       Date:  2017-03-03       Impact factor: 42.937

8.  Cognitive Impairment and Mortality in a Population-Based Parkinson's Disease Cohort.

Authors:  Adrienne M Keener; Kimberly C Paul; Aline Folle; Jeff M Bronstein; Beate Ritz
Journal:  J Parkinsons Dis       Date:  2018       Impact factor: 5.568

Review 9.  Treatment of Sleep Dysfunction in Parkinson's Disease.

Authors:  Amy W Amara; Lana M Chahine; Aleksandar Videnovic
Journal:  Curr Treat Options Neurol       Date:  2017-07       Impact factor: 3.598

10.  Hallucinations and Development of Dementia in Parkinson's Disease.

Authors:  Wojciech Gryc; Kathryn A Roberts; Cyrus P Zabetian; Daniel Weintraub; John Q Trojanowski; Joseph F Quinn; Amie L Hiller; Kathryn A Chung; Kathleen L Poston; Laurice Yang; Shu-Ching Hu; Karen L Edwards; Thomas J Montine; Brenna A Cholerton
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.